Company Filing History:
Years Active: 2010
Title: Rajarshi Pal: Innovator in Human Embryonic Stem Cell Research
Introduction
Rajarshi Pal is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of biotechnology, particularly in the area of human embryonic stem cell research. His work has implications for regenerative medicine and cellular therapies.
Latest Patents
Rajarshi Pal holds a patent for the establishment of a human embryonic stem cell line using mammalian cells. This patent describes purified preparations of human embryonic stem cells with specific population characteristics. The preparation is characterized by the positive expression of pluripotent cell surface markers such as SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. Additionally, it includes a set of embryonic stem cell markers like Oct-4, Nanog, and Sox2. The cells are negative for lineage-specific markers, indicating their pluripotent nature. The embryonic stem cell line, named Relicell™ hES1, retains the ability to differentiate into various cell and tissue types derived from all three embryonic germ layers.
Career Highlights
Rajarshi Pal is currently associated with Reliance Life Sciences Pvt. Ltd., where he continues to advance his research in stem cell technology. His work has been pivotal in understanding the characteristics and potential applications of human embryonic stem cells.
Collaborations
Rajarshi has collaborated with notable colleagues, including Arundhati Mandal and Shabari Pradeep Tipnis, to further enhance the research and development in the field of stem cell science.
Conclusion
Rajarshi Pal's innovative work in human embryonic stem cell research exemplifies the potential of biotechnology to transform medical science. His contributions are paving the way for future advancements in regenerative medicine.